Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Pancreatic Cancer and Renal Cancer in Patients Exposed to Gabapentin in the United Kingdom General Practice Research Database

NCT01138124 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01138124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01138124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Pancreatic Cancer and Renal Cancer in Patients Exposed to Gabapentin in the United Kingdom General Practice Research Database
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
August 31, 2010
Enrollment
54,202 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, diabetes, epilepsy, hypertension, neuropathic pain, pancreatic cancer, renal cancer, renal cell carcinoma, renal pelvis cancer, restless legs syndrome